A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. 1990

M R Brunetto, and M Stemler, and F Bonino, and F Schodel, and F Oliveri, and M Rizzetto, and G Verme, and H Will
Department of Gastroenterology, Molinette Hospital, Torino, Italy.

In hepatitis B virus carriers who are anti-HBe positive despite ongoing viral replication (HBcAg in liver and HBV-DNA in serum) the natural course of hepatitis is severe and the response to interferon is low. We investigated whether a new hepatitis B virus (HBV) strain could be involved. A translational termination codon at the carboxyterminal end of the pre-C region responsible for the lack of HBeAg secretion was found in 18 of 19 HBV clones isolated from seven pedigreed patients with this clinical syndrome. The same findings were confirmed by direct sequencing. One of these patients underwent a liver transplant and HBV infection of the new liver resulted in high titered viremia and intrahepatic expression of HBcAg, without detectable HBeAg in serum. Another patient was superinfected by hepatitis delta virus (HDV) and developed high titres of total and IgM anti-HD. In spite of this, chronic hepatitis remained unchanged during 7 years of follow-up. These data strongly suggest that a viable precore minus mutant of hepatitis B virus is responsible for the lack of HBeAg in the serum of these patients. The HBV variant may explain the peculiar geographic distribution of anti-HBe positive hepatitis. The variations in the virus genome sequence may cause the more severe form of liver disease and modify the pathogenicity in the case of HDV superinfection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis

Related Publications

M R Brunetto, and M Stemler, and F Bonino, and F Schodel, and F Oliveri, and M Rizzetto, and G Verme, and H Will
October 1995, Nihon rinsho. Japanese journal of clinical medicine,
M R Brunetto, and M Stemler, and F Bonino, and F Schodel, and F Oliveri, and M Rizzetto, and G Verme, and H Will
October 1995, Nihon rinsho. Japanese journal of clinical medicine,
M R Brunetto, and M Stemler, and F Bonino, and F Schodel, and F Oliveri, and M Rizzetto, and G Verme, and H Will
January 1993, Revista do Instituto de Medicina Tropical de Sao Paulo,
M R Brunetto, and M Stemler, and F Bonino, and F Schodel, and F Oliveri, and M Rizzetto, and G Verme, and H Will
January 2003, Intervirology,
M R Brunetto, and M Stemler, and F Bonino, and F Schodel, and F Oliveri, and M Rizzetto, and G Verme, and H Will
May 1992, Zhonghua nei ke za zhi,
M R Brunetto, and M Stemler, and F Bonino, and F Schodel, and F Oliveri, and M Rizzetto, and G Verme, and H Will
January 1995, Journal of hepatology,
M R Brunetto, and M Stemler, and F Bonino, and F Schodel, and F Oliveri, and M Rizzetto, and G Verme, and H Will
July 2001, Journal of viral hepatitis,
M R Brunetto, and M Stemler, and F Bonino, and F Schodel, and F Oliveri, and M Rizzetto, and G Verme, and H Will
June 1991, Revista clinica espanola,
M R Brunetto, and M Stemler, and F Bonino, and F Schodel, and F Oliveri, and M Rizzetto, and G Verme, and H Will
August 2002, The American journal of gastroenterology,
M R Brunetto, and M Stemler, and F Bonino, and F Schodel, and F Oliveri, and M Rizzetto, and G Verme, and H Will
June 1984, Liver,
Copied contents to your clipboard!